{
  "id": "cluster_4_doc6",
  "content": "Longitudinal study of autoimmune patients (n=412) shows biologic therapy adherence rates of 83% in Silverpine network versus 74% nationally. Study period covered 2020-2023. Medicare Advantage plans showed highest persistence rates among payers.",
  "metadata": {
    "format": "research_note"
  }
}